Lallemand Health Solutions has introduced a new probiotic formula called Cerenity, a blend of three flagship probiotic strains, designed to modulate the gut-muscle axis for healthy aging.

Studied in a new clinical trial, Cerenity, combined with a prebiotic, was shown to support mobility, strength, and quality of life.

The randomized, double-blind, placebo-controlled study investigated the effects of Cerenity supplementation on strength, physical performance, and muscle architecture in 64 healthy elderly individuals aged 60 to 85 years over a 16-week intake period, followed by a 4-week follow-up. Participants took 6 billion CFU of Cerenity and 900 mg of inulin, or a placebo, in one sachet (1.8 grams), dissolved in water, daily.

The study revealed significant improvement in mobility, coordination, endurance, and muscle strength compared to placebo as measured by handgrip strength, Short Physical Performance Battery and Timed Up and Go tests. It also showed significant improvement of the vastus intermedius muscle morphology compared to placebo, suggesting an increase in power in the quadricep area. The company said a manuscript is being prepared.

“As we age, gut health naturally evolves, leading to a decline in microbiota diversity and a reduction in beneficial bacteria,” said Camille Binachon, marketing group manager at Lallemand Health Solutions. “These changes can have a notable impact on muscle mass and function, reinforcing the link between gut microbiota and mobility. Recent studies emphasize the gut-muscle axis as a key factor in maintaining muscle strength, highlighting the influence of gut microbiota on physical performance. Our latest research sheds light on how specific probiotics can support this connection, offering a promising approach to improving mobility, strength, and overall well-being in older adults.”

Camille Binachon will present the details of this innovative study and its groundbreaking results during the Nutraceutical Showcase Theatre Presentation at Vitafoods Europe 2025 in Barcelona, Spain, on May 20-22. Lallemand Health Solutions will exhibit at stand #4C26.